Elsevier

World Neurosurgery

Volume 105, September 2017, Pages 406-411
World Neurosurgery

Original Article
Fluorescein Angiography in Intracranial Aneurysm Surgery: A Helpful Method to Evaluate the Security of Clipping and Observe Blood Flow

https://doi.org/10.1016/j.wneu.2017.05.172Get rights and content

Background

In cerebral aneurysm surgery, various tools are used to evaluate blood flow, including Doppler ultrasonography, conventional cerebral angiography, and electrophysiological monitoring. Fluorescein and indocyanine green are widely used in vascular and central nervous system tumor neurosurgery; however, their routine utilization in aneurysmal surgery is uncommon, despite the fact that they allow direct visualization of blood flow after aneurysmal sac occlusion, enabling the observation of vessel permeability and the effectiveness of aneurysmal obliteration. We report our initial experience using fluorescein video angiography as a control measure for proper clip placement and control of blood flow in aneurysm surgery, and review the relevant literature.

Methods

This pilot study presents an initial experience, with enrollment of 10 patients harboring a total of 12 cerebral aneurysms who underwent surgery via clipping and subsequent fluorescence videoangiography control. The intravenous injection was performed to demonstrate the patency of the arteries adjacent to the aneurysm.

Results

Following intravenous injection, fluorescein sodium remains in the cerebral vasculature for approximately 3 minutes, providing ample time to evaluate vessel patency and determine whether clip repositioning is needed. None of the patients experienced complications during intravenous injection of fluorescein sodium, and the patency of surrounding vessels was demonstrated in all cases.

Conclusions

Fluorescein injection in itself does not present a risk of complications, is simple to use, and offers a clear image of the cerebral vasculature. Thus, this technique is useful for determining vessel patency and the degree of aneurysmal occlusion.

Introduction

In cerebral aneurysm surgery, it is useful to confirm aneurysm obliteration and the patency of adjacent arteries.1 To view the blood flow in the vessels that surround the aneurysm, various intraoperative methods are utilized, such as Doppler ultrasonography, conventional cerebral angiography, and electrophysiological monitoring.2

Along with these methods, the literature describes intraoperative videoangiography (VA) using fluorescein sodium (FL) or indocyanine green (ICG) as the dye.2, 3, 4 Several studies have specifically addressed the utility of fluorescein in cerebral aneurysm surgery.2, 5 This technique can be highly useful for demonstrating the patency of parent arteries and determining whether an aneurysm is completely occluded.2 Aside from vascular surgery, fluorescein sodium is also currently being tested as an intraoperative guidance agent in the resection of high-grade gliomas.6

Neurosurgical centers, especially those with limited resources, require cost-effective tools in order to evaluate the quality of aneurysm surgery. Although extensive research has been published on the use of ICG-VA for assessment of proper aneurysm clipping and blood flow, data on the use of FL-VA in aneurysm surgery remains limited.7 The purpose of this article is to present our initial experience on using FL-VA, review the relevant literature and offer some suggestions on its utilization to other surgeons who want to adopt it.

Section snippets

Methods

Ten consecutive patients (7 females and 3 males) were enrolled in this study (Table 1). The inclusion criteria were subarachnoid hemorrhage (SAH) as a result of ruptured cerebral aneurysms and a Hunt and Hess (H&H) score of 1 to 4. The exclusion criteria were the lack of an SAH from a ruptured cerebral aneurysm and patients with SAH secondary to ruptured cerebral aneurysms with an H&H score of 5. Within this series, 12 aneurysms were diagnosed, with 9 patients harboring a single aneurysm and 1

Results

All of the patients enrolled in this pilot study received an intraoperative intravenous bolus of 5 mL of 10% fluorescein sodium immediately after aneurysm clipping. At approximately 15 seconds postinjection, the major cerebral vessels exhibited a yellowish-green tint in the yellow 560 light. In all cases except one (case 1; Figure 1), the aneurysm was properly occluded, whereas the neighboring arteries were permeable. In case 1, fluorescein injection demonstrated inappropriate clip placement,

Discussion

Here we present our initial experience with the use of FL-VA. Although the literature on the use of ICG-VA in aneurysm surgery has grown exponentially, the number of studies on FL-VA remains limited.7 Our pilot study shows that fluorescein can be a good compromise solution for neurosurgical centers with limited resources with no other means to demonstrate complete aneurysm occlusion and satisfactory restoration of blood flow.

As mentioned above, numerous methods are available for evaluating

Conclusions

FL-VA is a practical intraoperative tool that can demonstrate occlusion of an aneurysmal sac and reveal the patency of cerebral vessels surrounding the aneurysm after clipping. This procedure is low risk and can be implemented as a routine examination in vascular neurosurgery. An important advantage for FL-VA is that it can be performed without interrupting the surgical procedure and is useful in decreasing surgical complications. Based on our findings, we recommend the use of FL-VA to improve

References (24)

  • A. Durand et al.

    Intraoperative monitoring by imaging and electrophysiological techniques during giant intracranial aneurysm surgery

    Neurochirurgie

    (2016)
  • D. Bongetta et al.

    Low-cost fluorescein detection system for high-grade glioma surgery

    World Neurosurg

    (2016)
  • T. Ichikawa et al.

    Intra-arterial fluorescence angiography with injection of fluorescein sodium from the superficial temporal artery during aneurysm surgery: technical notes

    Neurol Med Chir (Tokyo)

    (2014)
  • K. Suzuki et al.

    Confirmation of blood flow in perforating arteries using fluorescein cerebral angiography during aneurysm surgery

    J Neurosurg

    (2007)
  • A. Raabe et al.

    Near-infrared indocyanine green video angiography: a new method for intraoperative assessment of vascular flow

    Neurosurgery

    (2003)
  • C.J. Wrobel et al.

    Intraoperative assessment of aneurysm clip placement by intravenous fluorescein angiography

    Neurosurgery

    (1994)
  • K. Kuroda et al.

    Intra-arterial injection fluorescein videoangiography in aneurysm surgery

    Neurosurgery

    (2013)
  • R.J. Diaz et al.

    Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance

    J Neurosurg

    (2015)
  • G.J. Zipfel

    Editorial: Clipping of neurosurgical aneurysms: the dye is cast

    J Neurosurg

    (2015)
  • T. Ichikawa et al.

    Development of and clinical experience with a simple device for performing intraoperative fluorescein fluorescence cerebral angiography: technical notes

    Neurol Med Chir (Tokyo)

    (2016)
  • H. Akdemir et al.

    Intraoperative microvascular Doppler sonography in aneurysm surgery

    Minim Invasive Neurosurg

    (2006)
  • R. Stendel et al.

    Intraoperative microvascular Doppler ultrasonography in cerebral aneurysm surgery

    J Neurol Neurosurg Psychiatry

    (2000)
  • Cited by (20)

    • Avoiding Complications in Aneurysm Ligation: Operative Tips and Tricks

      2022, World Neurosurgery
      Citation Excerpt :

      Another fluorophore agent available for intraoperative VA is fluorescein sodium (FNa). Although its first use in vascular neurosurgery dates before the use of ICG,53 to date, only few clinical series have assessed the role of this fluorophore agent in the treatment of intracranial aneurysms.54-61 FNa-VA, commonly available in modern neurosurgical microscopes, may overcome some of the difficulties with ICG-VA.

    • Intraoperative Fluorescein Sodium Videoangiography in Intracranial Aneurysm Surgery

      2021, World Neurosurgery
      Citation Excerpt :

      First introduced to neurosurgery in 1967, FNa is another fluorophore agent available for VA.5 FNa was applied to the treatment of intracranial aneurysms in 19946; however, there is no report to our knowledge focusing on the use of FNa in vascular neurosurgery until FNa-VA was discussed in the article by Suzuki et al. in 2007.13 Since then, only a handful of clinical series have been published focusing on the use of FNa-VA in clip ligation of intracranial aneurysm surgery.7,8,10,11,17 In contrast to the limited use of FNa in vascular neurosurgery, FNa-VA, commonly available in modern neurosurgical microscopes, such as YELLOW 560 (Carl Zeiss Meditec AG) and FL560 fluorescence modules, may overcome some of the difficulties with ICG-VA.

    • Excited state dipole moment of the fluorescein molecule estimated from electronic absorption spectra

      2019, Journal of Molecular Structure
      Citation Excerpt :

      Thus, a microscope-integrated fluorescence module renders fluorescein fluorescence technology is a valuable tool in the surgical management of neoplastic and vascular lesions [29]. This technique allows to maximize the resection of tumors and perform intraoperative angiography to guide microsurgical management of aneurysms and arteriovenous malformations [30,31]. A comprehensive review on the fluorescein-guided surgery of malignant gliomas can be found in Ref. [32].

    • Diagnostic Accuracy of a Confocal Laser Endomicroscope for In Vivo Differentiation Between Normal Injured And Tumor Tissue During Fluorescein-Guided Glioma Resection: Laboratory Investigation

      2018, World Neurosurgery
      Citation Excerpt :

      Fluorescein sodium (FNa), a drug approved by the U.S. Federal Drug Administration (FDA), is administered off-label to patients in fluorescence-guided resection of brain tumors using intraoperative imaging technology that can detect its emitted fluorescence. The use of FNa dates back to 19484; since then, its use in brain5-15 and spinal cord16 tumor surgery, brain abscesses,17,18 cerebrospinal fluid leaks,19,20 and cerebrovascular angiography application21-25 has been investigated and reviewed in multiple studies.26-29 For tumor application, FNa is administered intravenously at dosages of 2 to 20 mg/kg and accumulates in and around tumor tissue because of the disruption of the blood–brain barrier in this tissue.3

    View all citing articles on Scopus

    Conflict of interest statement: This study was supported by POSDRU (HRDSOP) Grant 159/1.5/S/138776. The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

    View full text